Annual CFF
$1.36 M
-$20.04 M-93.63%
December 31, 2024
Summary
- As of March 12, 2025, LUNG annual cash flow from financing activities is $1.36 million, with the most recent change of -$20.04 million (-93.63%) on December 31, 2024.
- During the last 3 years, LUNG annual CFF has fallen by -$3.09 million (-69.41%).
- LUNG annual CFF is now -99.42% below its all-time high of $234.83 million, reached on December 31, 2020.
Performance
LUNG Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$62.00 K
-$397.00 K-86.49%
December 1, 2024
Summary
- As of March 12, 2025, LUNG quarterly cash flow from financing activities is $62.00 thousand, with the most recent change of -$397.00 thousand (-86.49%) on December 1, 2024.
- Over the past year, LUNG quarterly CFF has dropped by -$397.00 thousand (-86.49%).
- LUNG quarterly CFF is now -99.97% below its all-time high of $199.76 million, reached on December 31, 2020.
Performance
LUNG Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$1.36 M
+$45.00 K+3.41%
December 1, 2024
Summary
- As of March 12, 2025, LUNG TTM cash flow from financing activities is $1.36 million, with the most recent change of +$45.00 thousand (+3.41%) on December 1, 2024.
- Over the past year, LUNG TTM CFF has increased by +$45.00 thousand (+3.41%).
- LUNG TTM CFF is now -99.42% below its all-time high of $234.83 million, reached on December 31, 2020.
Performance
LUNG TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LUNG Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -93.6% | -86.5% | +3.4% |
| 3 y3 years | -69.4% | -86.5% | +3.4% |
| 5 y5 years | -97.0% | -86.5% | +3.4% |
LUNG Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -93.6% | at low | -99.7% | +381.8% | -93.8% | +3.4% |
| 5 y | 5-year | -99.4% | at low | -100.0% | +381.8% | -99.4% | +4.2% |
| alltime | all time | -99.4% | at low | -100.0% | +381.8% | -99.4% | +4.2% |
Pulmonx Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.36 M(-93.6%) | - | - |
| Dec 2024 | - | $62.00 K(-86.5%) | $1.36 M(+3.4%) |
| Sep 2024 | - | $459.00 K(-2186.4%) | $1.32 M(-7.8%) |
| Jun 2024 | - | -$22.00 K(-102.5%) | $1.43 M(-7.4%) |
| Mar 2024 | - | $864.00 K(+4982.4%) | $1.54 M(-92.8%) |
| Dec 2023 | $21.40 M(+784.7%) | $17.00 K(-97.0%) | $21.40 M(-0.2%) |
| Sep 2023 | - | $571.00 K(+520.7%) | $21.45 M(-1.5%) |
| Jun 2023 | - | $92.00 K(-99.6%) | $21.79 M(-0.2%) |
| Mar 2023 | - | $20.72 M(>+9900.0%) | $21.82 M(+802.2%) |
| Dec 2022 | $2.42 M | $67.00 K(-92.6%) | $2.42 M(-3.3%) |
| Sep 2022 | - | $906.00 K(+591.6%) | $2.50 M(-3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $131.00 K(-90.0%) | $2.60 M(-54.9%) |
| Mar 2022 | - | $1.31 M(+776.7%) | $5.76 M(+29.2%) |
| Dec 2021 | $4.46 M(-98.1%) | $150.00 K(-85.0%) | $4.46 M(-97.8%) |
| Sep 2021 | - | $1.00 M(-69.6%) | $204.07 M(-0.7%) |
| Jun 2021 | - | $3.29 M(>+9900.0%) | $205.43 M(-12.0%) |
| Mar 2021 | - | $13.00 K(-100.0%) | $233.54 M(-0.6%) |
| Dec 2020 | $234.83 M(+414.8%) | $199.76 M(+8368.2%) | $234.83 M(+569.7%) |
| Sep 2020 | - | $2.36 M(-92.5%) | $35.07 M(+7.2%) |
| Jun 2020 | - | $31.40 M(+2300.5%) | $32.71 M(+2400.5%) |
| Mar 2020 | - | $1.31 M | $1.31 M |
| Dec 2019 | $45.62 M(+276.6%) | - | - |
| Dec 2018 | $12.11 M | - | - |
FAQ
- What is Pulmonx annual cash flow from financing activities?
- What is the all time high annual CFF for Pulmonx?
- What is Pulmonx annual CFF year-on-year change?
- What is Pulmonx quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Pulmonx?
- What is Pulmonx quarterly CFF year-on-year change?
- What is Pulmonx TTM cash flow from financing activities?
- What is the all time high TTM CFF for Pulmonx?
- What is Pulmonx TTM CFF year-on-year change?
What is Pulmonx annual cash flow from financing activities?
The current annual CFF of LUNG is $1.36 M
What is the all time high annual CFF for Pulmonx?
Pulmonx all-time high annual cash flow from financing activities is $234.83 M
What is Pulmonx annual CFF year-on-year change?
Over the past year, LUNG annual cash flow from financing activities has changed by -$20.04 M (-93.63%)
What is Pulmonx quarterly cash flow from financing activities?
The current quarterly CFF of LUNG is $62.00 K
What is the all time high quarterly CFF for Pulmonx?
Pulmonx all-time high quarterly cash flow from financing activities is $199.76 M
What is Pulmonx quarterly CFF year-on-year change?
Over the past year, LUNG quarterly cash flow from financing activities has changed by -$397.00 K (-86.49%)
What is Pulmonx TTM cash flow from financing activities?
The current TTM CFF of LUNG is $1.36 M
What is the all time high TTM CFF for Pulmonx?
Pulmonx all-time high TTM cash flow from financing activities is $234.83 M
What is Pulmonx TTM CFF year-on-year change?
Over the past year, LUNG TTM cash flow from financing activities has changed by +$45.00 K (+3.41%)